Treatment of Peptic Ulcer Disease in Children
Initial Pharmacological Management
- The American Academy of Pediatrics recommends initiating proton pump inhibitor (PPI) therapy immediately at a dose of 1 mg/kg/day (maximum 20-40 mg daily) for 6-8 weeks, testing all children for H. pylori infection, and eradicating if positive using standard triple therapy for 14 days 1
- The standard dosing of PPIs translates to omeprazole 20 mg, lansoprazole 30 mg, or pantoprazole 40 mg once daily for 6-8 weeks to achieve complete mucosal healing 1
Management of Bleeding Peptic Ulcers
- Administer high-dose PPI therapy: 80 mg bolus followed by 8 mg/hour continuous infusion for 72 hours, then transition to standard oral PPI therapy 1, 2
- Perform urgent endoscopy for diagnosis and hemostasis—PPIs should not replace endoscopy in active bleeding 1
- Consider pre-endoscopy erythromycin to improve visualization and reduce need for repeat procedures 1, 2
Helicobacter pylori Testing and Eradication
- Test all children with peptic ulcers for H. pylori infection, as failure to eradicate leads to 40-50% recurrence rates over 10 years 1
- Standard triple therapy for 14 days consists of PPI standard dose twice daily, clarithromycin 500 mg twice daily, and amoxicillin 1000 mg twice daily 1, 3, 4
- Start this regimen after 72-96 hours of intravenous PPI administration in complicated cases 3, 4, 5
NSAID-Associated Peptic Ulcers in Children
- Discontinue NSAID therapy whenever clinically feasible—this is the most effective intervention, healing 95% of ulcers and reducing recurrence from 40% to 9% 1
- If NSAIDs must be continued, maintain PPI therapy long-term to prevent recurrence 1, 2
Duration of PPI Therapy
- Standard uncomplicated ulcers require 6-8 weeks of PPI therapy 1
- Long-term PPI therapy is only indicated for children requiring continuous NSAID therapy or those with recurrent ulcers despite H. pylori eradication 1, 2
Critical Pitfalls to Avoid
- Never skip H. pylori testing—this accounts for the majority of treatment failures and recurrences 1
- Do not use PPIs as a substitute for urgent endoscopy in children with signs of active bleeding (hematemesis, melena, hemodynamic instability) 1, 2
- Avoid H2-receptor antagonists as first-line therapy in children—they are ineffective for gastric ulcers at standard doses 1
- Be aware of PPI drug interactions—PPIs may reduce absorption of medications requiring acidic environments (ketoconazole, iron, certain antiretrovirals) 1
Monitoring and Follow-Up
- Most children requiring endoscopic hemostasis for high-risk stigmata should be hospitalized for at least 72 hours, as 60-76% of rebleeding episodes occur within this timeframe 2
- After initial healing, discharge with single daily-dose oral PPI for duration dictated by underlying etiology 2
- Confirm H. pylori eradication after treatment completion to ensure successful therapy 1, 2